合計 50 件の最近のインサイダー取引記録が記録されています Actinium Pharmaceuticals, Inc. (ATNM), 内訳は 41 件の買い および 8 件の売り. インサイダー買い総額は $16.44M インサイダー売り総額は $2.15M.
最近活動のある主要インサイダーには Seth Sandesh, Steinhart Richard I, Almenoff June Sherie. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — ATNM
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-08-18 |
Seth Sandesh |
Chief Executive Officer |
RSU 源泉徴収 |
120,900 |
$1.71 |
$206.74K |
184,481 |
| 2025-03-31 |
Steinhart Richard I |
Director |
株式返還 |
2,500 |
$59.70 |
$149.25K |
- |
| 2025-03-31 |
Almenoff June Sherie |
Director |
株式返還 |
50,000 |
$1.71 |
$85.5K |
- |
| 2025-03-31 |
Seth Sandesh |
Chief Executive Officer |
株式返還 |
33,333 |
$23.49 |
$782.99K |
- |
| 2025-03-31 |
O'loughlin Steve |
Chief Financial Officer |
株式返還 |
3,333 |
$41.70 |
$138.99K |
- |
| 2025-03-31 |
Nicholson, C. David |
Director |
株式返還 |
70,311 |
$5.00 |
$351.56K |
- |
| 2025-03-31 |
Shetty Ajit |
Director |
株式返還 |
72,156 |
$4.96 |
$357.89K |
- |
| 2025-03-31 |
Chell Jeffrey W. |
Director |
株式返還 |
8,333 |
$9.55 |
$79.58K |
- |
| 2024-11-01 |
Almenoff June Sherie |
Director |
不明 |
- |
- |
- |
- |
| 2024-11-01 |
Almenoff June Sherie |
Director |
RSU 付与(制限付株式) |
50,000 |
$1.71 |
$85.5K |
50,000 |
| 2023-12-28 |
Steinhart Richard I |
Director |
RSU 付与(制限付株式) |
70,311 |
$5.00 |
$351.56K |
70,311 |
| 2023-12-28 |
Seth Sandesh |
Chief Executive Officer |
RSU 付与(制限付株式) |
984,367 |
$5.00 |
$4.92M |
984,367 |
| 2023-12-28 |
O'loughlin Steve |
Chief Financial Officer |
RSU 付与(制限付株式) |
253,123 |
$5.00 |
$1.27M |
253,123 |
| 2023-12-28 |
Nicholson, C. David |
Director |
RSU 付与(制限付株式) |
70,311 |
$5.00 |
$351.56K |
70,311 |
| 2023-12-28 |
Shetty Ajit |
Director |
RSU 付与(制限付株式) |
70,311 |
$5.00 |
$351.56K |
70,311 |
| 2023-12-28 |
Chell Jeffrey W. |
Director |
RSU 付与(制限付株式) |
70,311 |
$5.00 |
$351.56K |
70,311 |
| 2022-08-17 |
Seth Sandesh |
Chief Executive Officer |
RSU 付与(制限付株式) |
300,000 |
- |
- |
305,381 |
| 2022-07-01 |
Steinhart Richard I |
Director |
RSU 付与(制限付株式) |
72,156 |
- |
- |
72,156 |
| 2022-07-01 |
Seth Sandesh |
Chief Executive Officer |
RSU 付与(制限付株式) |
827,366 |
- |
- |
827,366 |
| 2022-07-01 |
O'loughlin Steve |
Chief Financial Officer |
RSU 付与(制限付株式) |
256,438 |
$4.96 |
$1.27M |
256,348 |
| 2022-07-01 |
Nicholson, C. David |
Director |
RSU 付与(制限付株式) |
72,156 |
- |
- |
72,156 |
| 2022-07-01 |
Shetty Ajit |
Director |
RSU 付与(制限付株式) |
72,156 |
- |
- |
72,156 |
| 2022-07-01 |
Chell Jeffrey W. |
Director |
RSU 付与(制限付株式) |
72,156 |
- |
- |
72,156 |
| 2021-09-01 |
Steinhart Richard I |
Director |
RSU 付与(制限付株式) |
18,351 |
$6.07 |
$111.39K |
18,351 |
| 2021-09-01 |
Seth Sandesh |
Chief Executive Officer |
RSU 付与(制限付株式) |
310,182 |
$6.07 |
$1.88M |
310,182 |
| 2021-09-01 |
O'loughlin Steve |
Chief Financial Officer |
RSU 付与(制限付株式) |
107,463 |
$6.07 |
$652.3K |
107,463 |
| 2021-09-01 |
Nicholson, C. David |
Director |
RSU 付与(制限付株式) |
18,351 |
$6.07 |
$111.39K |
18,351 |
| 2021-09-01 |
Shetty Ajit |
Director |
RSU 付与(制限付株式) |
18,351 |
$6.07 |
$111.39K |
18,351 |
| 2021-09-01 |
Berger Mark Stanley |
Chief Medical Officer |
RSU 付与(制限付株式) |
67,164 |
$6.07 |
$407.69K |
67,164 |
| 2021-09-01 |
Chell Jeffrey W. |
Director |
RSU 付与(制限付株式) |
18,351 |
$6.07 |
$111.39K |
18,351 |
| 2020-08-12 |
Steinhart Richard I |
Director |
RSU 付与(制限付株式) |
8,333 |
$9.55 |
$79.58K |
8,333 |
| 2020-08-12 |
Seth Sandesh |
Chief Executive Officer |
RSU 付与(制限付株式) |
139,062 |
$9.55 |
$1.33M |
139,062 |
| 2020-08-12 |
O'loughlin Steve |
Chief Financial Officer |
RSU 付与(制限付株式) |
59,066 |
$9.55 |
$564.08K |
59,066 |
| 2020-08-12 |
Nicholson, C. David |
Director |
RSU 付与(制限付株式) |
8,333 |
$9.55 |
$79.58K |
8,333 |
| 2020-08-12 |
Shetty Ajit |
Director |
RSU 付与(制限付株式) |
8,333 |
$9.55 |
$79.58K |
8,333 |
| 2020-08-12 |
Berger Mark Stanley |
Chief Medical Officer |
RSU 付与(制限付株式) |
46,667 |
$9.55 |
$445.67K |
46,667 |
| 2020-08-12 |
Ludwig Dale L. |
Chief Science & Tech. Officer |
RSU 付与(制限付株式) |
50,000 |
$9.55 |
$477.5K |
50,000 |
| 2020-08-12 |
Chell Jeffrey W. |
Director |
RSU 付与(制限付株式) |
8,333 |
$9.55 |
$79.58K |
8,333 |
| 2019-07-12 |
Steinhart Richard I |
Director |
RSU 付与(制限付株式) |
250,000 |
$0.23 |
$58K |
250,000 |
| 2019-07-12 |
Seth Sandesh |
CEO |
RSU 付与(制限付株式) |
1,500,000 |
$0.23 |
$348K |
1,500,000 |
| 2019-07-12 |
O'loughlin Steve |
Principal Financial Officer |
RSU 付与(制限付株式) |
400,000 |
$0.23 |
$92.8K |
400,000 |
| 2019-07-12 |
Nicholson, C. David |
Director |
RSU 付与(制限付株式) |
250,000 |
$0.23 |
$58K |
250,000 |
| 2019-07-12 |
Shetty Ajit |
Director |
RSU 付与(制限付株式) |
250,000 |
$0.23 |
$58K |
250,000 |
| 2019-07-12 |
Berger Mark Stanley |
Chief Medical Officer |
RSU 付与(制限付株式) |
400,000 |
$0.23 |
$92.8K |
400,000 |
| 2019-07-12 |
Ludwig Dale L. |
Chief Scientific Officer |
RSU 付与(制限付株式) |
400,000 |
$0.23 |
$92.8K |
400,000 |
| 2019-07-12 |
Kapur Anil |
Chief Commercial Officer |
RSU 付与(制限付株式) |
400,000 |
$0.23 |
$92.8K |
400,000 |
| 2019-07-12 |
Chell Jeffrey W. |
Director |
RSU 付与(制限付株式) |
250,000 |
$0.23 |
$58K |
250,000 |
| 2019-03-05 |
Berger Mark Stanley |
Chief Medical Officer |
オプション行使(ITM) |
3,500 |
$0.60 |
$2.1K |
22,500 |
| 2019-02-21 |
Seth Sandesh |
Chairman & CEO |
オプション行使(ITM) |
8,125 |
$0.60 |
$4.88K |
161,458 |
| 2018-12-10 |
Seth Sandesh |
Chairman & CEO |
情報に基づく買い |
10,000 |
$0.44 |
$4.37K |
153,333 |
■ 情報付き — 公開市場取引(最も重要)
■ 情報なし(買い) — 報酬・オプション行使・転換
■ 情報なし(売り) — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効